In the presence of K.T Rama Rao, Telangana's Minister for Municipal Administration and Urban Development, Industries and Commerce, and Information Technology, Electronics, and Communications, Bharat Serums and Vaccines Limited (BSV) held the groundbreaking ceremony for its new manufacturing plant at Genome Valley in Hyderabad, Telangana.

BSV currently has a manufacturing facility in Ambernath, Maharashtra, that serves the domestic market and more than 80 export markets, as well as a manufacturing facility in Aachen, Germany, that serves international markets.

The new manufacturing facility in Genome Valley will be 10 acres in size and will cost Rs 200 crore.  It aims to provide long-term employment opportunities as well as capability upskilling to the people of Telangana State.

With the commissioning of the fill-finish formulation line in phase 1 and an additional multi-product line in phase 2 of the project, BSV hopes to significantly increase its capacity in producing injectables. The manufacturing facility strives to produce world-class products that adhere to International Quality Systems while adhering to Indian Schedule M regulatory norms as well as global regulatory requirements. The plant will manufacture women's health products, rabies vaccines, immunoglobulins, and hormones, among other things.